v3.22.2.2
Stockholders’ Equity
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Stockholders’ Equity

16. Stockholders’ Equity

Schedule of Stockholders’ Equity 

                                    
  

Series B

Preferred Stock

   Common Stock   Paid-in   Accumulated  

Total

Stockholders’

 
(Shares and dollars in thousands)  Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance, December 31, 2021   2,500   $          -    14,791   $      1   $72,003   $(58,605)  $        13,399 
                                    
Stock-based compensation   -    -    -    -    3    -    3 
Issuance of common stock for services by third parties   -    -    286    -    230    -    230 
Issuance of common stock for services by employees   -    -    170    -    206    -    206 
Issuance of detachable warrants on notes payable   -    -    -    -    1,590    -    1,590 
Shares issued for cash   -    -    200    1    196    -    197 
Preferred stock dividends   -    -    -    -    -    (113)   (113)
Net loss   -    -    -    -    -    (6,557)   (6,557)
Balance, September 30, 2022   2,500   $-    15,447   $2   $74,228   $(65,275)  $8,955 

 

Issuance of Common Stock

 

During the nine months ended September 30, 2022, the Company issued 455,245 shares of common stock to directors and employees for stock-based compensation of $0.4 million. The shares were valued using the closing share price of the Company’s common stock on the date of grant, within the range of $0.69 to $1.21 per share. Of these shares, 170,000 were issued to the Company’s former Chief Executive Officer pursuant to his separation agreement.

 

On April 5, 2022, the Company sold 200,000 shares of common stock to its Chief Executive Officer for proceeds of $0.2 million based on the market price of the stock at that date.

 

During 2021, the Company issued 313,442 shares of common stock to directors and employees for stock-based compensation of $0.6 million. The shares were valued using the closing share price of the Company’s common stock on the date of grant, within the range of $1.28 to $2.98 per share. In addition, the Company issued 5,000 shares of its common stock upon the exercise of stock options at $1.23 per share.

 

On February 10, 2021 and April 19, 2021, the Company issued 1.2 million shares and 682,669 shares, respectively, of its common stock (the “Shares”) to certain affiliates of Intersect pursuant to an Asset Purchase Agreement dated September 12, 2019 by and between the Company and Intersect in respect of the Azuñia Tequila acquisition at a weighted-average of $4.67 per share and $1.82 per share, respectively. The Shares constitute the “Fixed Shares” due to Intersect pursuant to the Asset Purchase Agreement.

 

On July 30, 2021, the Company entered into Inducement Letters with the holders of the Existing Warrants to exercise their Existing Warrants and purchased 900,000 shares of common stock for gross proceeds of $2.4 million.

 

 

Eastside Distilling, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

September 30, 2022

(Unaudited)

 

During 2021, the Company sold 1,297,653 shares of common stock for net proceeds of $3.6 million in at-the-market public placements.

 

Issuance of Series B Preferred Stock

 

On October 19, 2021, Company entered into a securities purchase agreement (“Purchase Agreement”) with an accredited investor (“Subscriber”) for its purchase of 2.5 million shares (“Preferred Shares”) of Series B Convertible Preferred Stock (“Series B Preferred Stock”) at a purchase price of $1.00 per Preferred Share, which Preferred Shares are convertible into shares of the Company’s common stock pursuant to the terms and conditions set forth in a Certificate of Designation Establishing Series B Preferred Stock of the Company with an initial conversion price of $3.10 per share. 850,000 shares of common stock were reserved for issuance in the event of conversion of the Preferred Shares.

 

The Series B Preferred Stock accrues dividends at a rate of 6% per annum, payable annually on the last day of December of each year. Dividends shall accrue from day to day, whether or not declared, and shall be cumulative. Dividends are payable at the Company’s option either in cash or “in kind” in shares of common stock; provided, however that dividends may only be paid in cash following the fiscal year in which the Company has net income (as shown in its audited financial statements contained in its Annual Report on Form 10-K for such year) of at least $0.5 million. For “in-kind” dividends, holders will receive that number of shares of common stock equal to (i) the amount of the dividend payment due such stockholder divided by (ii) the volume weighted average price of the common stock for the 90 trading days immediately preceding a dividend date (“VWAP”). For the year ended December 31, 2021, the Company issued as dividends 10,670 shares of common stock at a VWAP of $2.57 per share. For the nine months ended September 30, 2022, the Company accrued $0.1 million of preferred dividends.

 

Stock-Based Compensation

 

On September 8, 2016, the Company adopted the 2016 Equity Incentive Plan (the “2016 Plan”). Pursuant to the terms of the plan, on January 1, 2022 the number of shares available for grant under the 2016 Plan reset to 5,225,141 shares, equal to 8% of the number of outstanding shares of the Company’s capital stock, calculated on an as-converted basis, on March 31 of the preceding calendar year, and then added to the prior year plan amount. As of September 30, 2022, there were 56,752 options and 1,607,291 restricted stock units (“RSUs”) outstanding under the 2016 Plan, with vesting schedules varying between immediate or three (3) years from the grant date.

 

The Company also issues, from time to time, options that are not registered under a formal option plan. As of September 30, 2022, there were no options outstanding that were not issued under the Plans.

 

A summary of all stock option activity as of and for the nine months ended September 30, 2022 is presented below:

 

   # of Options   Weighted-
Average
Exercise Price
 
Outstanding as of December 31, 2021   57,586   $3.29 
           
Options canceled   (5,834)   4.43 
Outstanding as of September 30, 2022   51,752   $3.16 
           
Exercisable as of September 30, 2022   51,585   $3.16 

 

On December 7, 2021, the Company issued 5,000 shares of common stock at $1.23 per share upon the exercise of stock options for proceeds of $6,150.

 

The aggregate intrinsic value of options outstanding as of September 30, 2022 was $0.

 

As of September 30, 2022, there were 167 unvested options with an aggregate grant date fair value of $66.70. The unvested options will vest in accordance with the vesting schedule in each respective option agreement, which varies between immediate and three years from the grant date. The aggregate intrinsic value of unvested options as of September 30, 2022 was $0. During the nine months ended September 30, 2022, 3,417 options vested.

 

 

Eastside Distilling, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

September 30, 2022

(Unaudited)

 

The Company uses the Black-Scholes valuation model to measure the grant-date fair value of stock options. The grant-date fair value of stock options issued to employees is recognized on a straight-line basis over the requisite service period. Stock-based awards issued to nonemployees are recorded at fair value on the measurement date and are subject to periodic market adjustments as the underlying stock-based awards vest.

 

To determine the fair value of stock options using the Black-Scholes valuation model, the calculation takes into consideration the effect of the following:

 

  Exercise price of the option
  Fair value of the Company’s common stock on the date of grant
  Expected term of the option
  Expected volatility over the expected term of the option
  Risk-free interest rate for the expected term of the option

 

The calculation includes several assumptions that require management’s judgment. The expected term of the options is calculated using the simplified method described in GAAP. The simplified method defines the expected term as the average of the contractual term and the vesting period. Estimated volatility is derived from volatility calculated using historical closing prices of common shares of similar entities whose share prices are publicly available for the expected term of the options. The risk-free interest rate is based on the U.S. Treasury constant maturities in effect at the time of grant for the expected term of the options.

 

The Company did not issue any additional options during the nine months ended September 30, 2022.

 

For the nine months ended September 30, 2022 and 2021, net compensation expense related to stock options was $2,926 and $0.1 million, respectively. As of September 30, 2022, the total compensation expense related to stock options not yet recognized was approximately $0.1 million, which is expected to be recognized over a weighted-average period of approximately 0.3 years.

 

Warrants

 

On March 21, 2022, the Company entered into a promissory note with TQLA to accept a one year loan of $2.0 million with a conditional additional loan of $1.0 million and a conditional term extension of six months. On August 4, 2022, the Company and TQLA amended and restated the note payable to increase the line of credit by an additional $500k, to $3.5 million. The loan bears interest at 9.25% and carries a commitment fee of 2.5%. In addition, the Company issued a common stock purchase warrant to TQLA covering the loan amount with a common stock value of $1.20 per share. As of September 30, 2022, the Company has drawn down $3.5 million of the note payable and issued 2.9 million warrants. The estimated fair value of the warrants of $1.6 million was recorded as debt issuance cost and is being amortized to interest expense over the maturity period of the promissory note, with $0.8 million recorded during the nine months ended September 30, 2022.

 

The estimated fair value of the new warrants issued was based on a combination of closing market trading price on the date of issuance for the public offering warrants, and the Black-Scholes option-pricing model, using the assumptions below:

 

Volatility   75%
Risk-free interest rate   2.6%
Expected term (in years)   5.0 
Expected dividend yield   - 
Fair value of common stock  $0.71 

 

From April 19, 2021 through May 12, 2021, the Company issued in a private placement Existing Warrants to purchase up to 900,000 shares of common stock at an exercise price of $2.60 per Warrant Share. The estimated fair value of the warrants of $0.7 million was recorded as debt issuance cost and is being amortized to interest expense over the maturity period of the secured credit facility, with $0.4 million recorded during the nine months ended September 30, 2022.

 

 

Eastside Distilling, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

September 30, 2022

(Unaudited)

 

On July 30, 2021, the Company entered into Inducement Letters with the holders of the Existing Warrants whereby such holders agreed to exercise for cash their Existing Warrants to purchase the 900,000 Warrant Shares in exchange for the Company’s agreement to issue new warrants (the “New Warrants”) to purchase up to 900,000 shares of common stock (the “New Warrant Shares”). The New Warrants have substantially the same terms as the Existing Warrants, except that the New Warrants have an exercise price of $3.00 per share and are exercisable until August 19, 2026. The Company received gross proceeds of $2.4 million on the exercise of the outstanding warrants, and recognized a deemed dividend of $2.3 million based on the Black Scholes valuation as a result of the higher strike price on the July 2021 issued warrants, which is included in additional paid-in capital in the consolidated balance sheets.

 

A summary of all warrant activity as of and for the nine months ended September 30, 2022 is presented below:

 

   Warrants   Weighted-
Average
Remaining
Life (Years)
   Weighted-
Average
Exercise
Price
   Aggregate
Intrinsic
Value
 
Outstanding as of December 31, 2021   1,256,944    4.0   $3.42   $         - 
                     
Granted   2,916,667    4.3    1.20    - 
Outstanding as of September 30, 2022   4,173,611    4.0   $1.79   $-